Arena Pharmaceuticals Profit Margin

The latest profit margin for ARNA is -1141542.59% as of December 2021. That compares with -126875.86% in the prior-year period — down 799.7% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Arena Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARNA's profit margin moved from -126875.86% to -1141542.59% — a 799.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arena Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, ARNA currently prints -1141542.59% for profit margin, while the sector average sits near 15.29%. That is roughly 7464633.0% below the sector mean. Large gaps often invite a closer look at Arena Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Arena Pharmaceuticals converts resources into returns. At -1141542.59%, ARNA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -126875.86% in the prior-year period — down 799.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARNA's profit margin (-1141542.59%), review year-over-year change from -126875.86%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.